Christos J Petropoulos
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2001First federal award
$11.9MFederal grants as PI24 awards
2Patents grantedLatest Oct 4, 2022
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
24 awards · $11.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 15, 2014 | NIH | NIH R21 Quantitative Viral Outgrowth Assays with Improved Throughput and Performance | $125K | — |
| Jul 15, 2014 | NIH | NIH R21 Assessing Potential Latent Virus HIV-1 Viability using Next Generation Sequencing | $100K | — |
| Jul 15, 2014 | NIH | NIH R21 Assessing Potential Latent Virus HIV-1 Viability using Next Generation Sequencing | $175K | — |
| Jul 15, 2014 | NIH | NIH R21 Quantitative Viral Outgrowth Assays with Improved Throughput and Performance | $150K | — |
| Mar 1, 2009 | NIH | SBIR/STTR Phase I Novel Assays for Measuring Susceptibility to Inhibitors that Target HIV1 Virion A | $299K | — |
| Mar 1, 2009 | NIH | SBIR/STTR Phase I Novel Assays for Measuring Susceptibility to Inhibitors that Target HIV1 Virion A | $300K | — |
| Mar 1, 2005 | NIH | SBIR/STTR Phase II HIV-1/SIV Antibody Neutralization Assay Improvements and Database Development | $1.0M | — |
| Mar 1, 2005 | NIH | SBIR/STTR Phase II HIV-1/SIV Antibody Neutralization Assay Improvements and Database Development | $1.0M | — |
| Mar 1, 2005 | NIH | SBIR/STTR Phase I Assay/Measuring HIV-1 and SIV Antibody Neutralization | $299K | — |
| Mar 1, 2005 | NIH | SBIR/STTR Phase I Assay/Measuring HIV-1 and SIV Antibody Neutralization | $309K | — |
| Jul 1, 2004 | NIH | SBIR/STTR Phase II HIV-1/SIV Antibody Neutralization Assay Improvements and Database Development | $1.0M | — |
| Aug 1, 2003 | NIH | SBIR/STTR Phase II The Development of a Web-based Data Retrieval System for HIV Therapy Guidance | $959K | — |
| Aug 1, 2003 | NIH | SBIR/STTR Phase II The Development of a Web-based Data Retrieval System for HIV Therapy Guidance | $933K | — |
| Jul 1, 2003 | NIH | SBIR/STTR Phase II Novel Assays for measuring Integrase and RNase-H Inhibition | $839K | — |
| Jul 1, 2003 | NIH | SBIR/STTR Phase I ASSAYS FOR MEASURING THE INHIBITION OF HIV-1 ENZYMES | $300K | — |
| Jul 1, 2003 | NIH | SBIR/STTR Phase I ASSAYS FOR MEASURING THE INHIBITION OF HIV-1 ENZYMES | $300K | — |
| Jul 1, 2001 | NIH | SBIR/STTR Phase I A novel assay for measuring HIV-1 replication capacity | $295K | — |
| Jul 1, 2001 | NIH | SBIR/STTR Phase I A novel assay for measuring HIV-1 replication capacity | $295K | — |
| May 1, 2001 | NIH | SBIR/STTR Phase I NOVEL ASSAY FOR MEASURING THE INHIBITION OF HIV-1 ENTRY | $300K | — |
| May 1, 2001 | NIH | SBIR/STTR Phase II NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY | $842K | — |
| May 1, 2001 | NIH | SBIR/STTR Phase II NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY | $802K | — |
| May 1, 2001 | NIH | SBIR/STTR Phase I NOVEL ASSAY FOR MEASURING THE INHIBITION OF HIV-1 ENTRY | $300K | — |
| May 1, 2001 | NIH | SBIR/STTR Phase II NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY | $777K | — |
| May 1, 2001 | NIH | SBIR/STTR Phase II NOVEL ASSAYS FOR MEASURING THE INHIBITION OF VIRUS ENTRY | $200K | — |
3 patents as inventor
- US 10550441Feb 4, 2020
- US 11459624Oct 4, 2022
- US —
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#11
Awards as PI#6
Patents#8
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.